Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke

NCT02258880 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped study was stopped for business/administrative reasons and not for patient safety concerns

Conditions

Stroke

Interventions

DRUG: SUN13837
DRUG: placebo

Sponsor

Daiichi Sankyo

Collaborators

[object Object]